The journey of Indian pharmaceutical companies exemplifies a synergistic blend of economic viability and social responsibility, positioning them as true leaders in the pursuit of global health equity.
Is this the end of the Ranbaxy fairytale? Japanese owners thinking of renaming company!
Ranbaxy gets assistance from the health ministry
Ranbaxy spurious drugs update: DCGI probe will take a month, Apollo suspends sales
Ranbaxy spurious drugs case: Indian Medical Association asks DCGI to investigate quality of Ranbaxy drugs in India
Ranbaxy spurious drugs case: Jaslok hospital asks docs not to prescribe Ranbaxy drugs
Ranbaxy spurious drugs case: Indian pharma laws different from that of USFDA
Ranbaxy spurious drugs case: Former Chairman Malvinder Singh hits back at Daiichi Sankyo
Ranbaxy spurious drugs case: Japanese owners Daiichi Sankyo considering legal action against Singh brothers
Will Ranbaxy's mistakes harm Indian pharma's image?
The journey of Indian pharmaceutical companies exemplifies a synergistic blend of economic viability and social responsibility, positioning them as true leaders in the pursuit of global health equity.
Is this the end of the Ranbaxy fairytale? Japanese owners thinking of renaming company!
Ranbaxy gets assistance from the health ministry
Ranbaxy spurious drugs update: DCGI probe will take a month, Apollo suspends sales
Ranbaxy spurious drugs case: Indian Medical Association asks DCGI to investigate quality of Ranbaxy drugs in India
Ranbaxy spurious drugs case: Jaslok hospital asks docs not to prescribe Ranbaxy drugs
Ranbaxy spurious drugs case: Indian pharma laws different from that of USFDA
Ranbaxy spurious drugs case: Former Chairman Malvinder Singh hits back at Daiichi Sankyo
Ranbaxy spurious drugs case: Japanese owners Daiichi Sankyo considering legal action against Singh brothers
Will Ranbaxy's mistakes harm Indian pharma's image?
